Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.
2.

CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.

Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR.

Int J Oncol. 2012 Jul;41(1):211-8. doi: 10.3892/ijo.2012.1453. Epub 2012 Apr 30.

PMID:
22552741
3.

shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells.

Park YS, Huh JW, Lee JH, Kim HR.

Oncol Rep. 2012 Feb;27(2):339-46. doi: 10.3892/or.2011.1532. Epub 2011 Nov 8.

PMID:
22076607
4.

Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells.

He SB, Yuan Y, Wang L, Yu MJ, Zhu YB, Zhu XG.

J Exp Clin Cancer Res. 2011 Nov 22;30:109. doi: 10.1186/1756-9966-30-109.

6.

Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.

Rao Y, Wang H, Fan L, Chen G.

J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):1-9. doi: 10.1007/s11596-011-0141-9. Epub 2011 Feb 19.

PMID:
21336715
7.

Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.

Song ZY, Gao ZH, Chu JH, Han XZ, Qu XJ.

Biomed Pharmacother. 2015 Apr;71:46-52. doi: 10.1016/j.biopha.2015.01.020. Epub 2015 Jan 15.

PMID:
25960214
8.

Silencing of pancreatic adenocarcinoma upregulated factor by RNA interference inhibits the malignant phenotypes of human colorectal cancer cells.

Liu PF, Wu YY, Hu Y, Wang L, He SB, Zhu YB, Zhu XG.

Oncol Rep. 2013 Jul;30(1):213-20. doi: 10.3892/or.2013.2478. Epub 2013 May 15.

PMID:
23677445
9.

Oligodeoxyribozymes that cleave beta-catenin messenger RNA inhibit growth of colon cancer cells via reduction of beta-catenin response transcription.

Choi BR, Gwak J, Kwon HM, Oh S, Kim KP, Choi WH, Cho YH, Kim DE.

Mol Cancer Ther. 2010 Jun;9(6):1894-902. doi: 10.1158/1535-7163.MCT-10-0056. Epub 2010 May 25.

11.

Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.

Zhang N, Zhang J, Shuai L, Zha L, He M, Huang Z, Wang Z.

Int J Oncol. 2012 Jun;40(6):2038-48. doi: 10.3892/ijo.2012.1395. Epub 2012 Mar 7.

PMID:
22407433
12.

[Effect of siRNA-mediated beta-catenin gene on Wnt signal pathway in lung adenocarcinoma A549 cell].

Teng Y, Wang XW, Wang YW, Wang J.

Zhonghua Yi Xue Za Zhi. 2010 Apr 13;90(14):988-92. Chinese.

PMID:
20646651
13.

[Relationship between MTA1 expression and invasive and metastatic ability of cervical cancer cell].

Han XY, Qian HL, Yang JJ, Zhang XY, Fu M, Liang X, Lin C, Xiang Y.

Zhonghua Fu Chan Ke Za Zhi. 2011 Sep;46(9):678-83. Chinese.

PMID:
22176993
14.

[Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells].

Xinxin H, Meng Z, Guiyu Z.

Zhonghua Fu Chan Ke Za Zhi. 2014 May;49(5):360-5. Chinese.

PMID:
25030733
15.
16.

Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells.

Wu XL, Lin KJ, Bai AP, Wang WX, Meng XK, Su XL, Hou MX, Dong PD, Zhang JJ, Wang ZY, Shi L.

World J Gastroenterol. 2014 Aug 14;20(30):10440-8. doi: 10.3748/wjg.v20.i30.10440.

17.

Ribonucleotide reductase small subunit p53R2 promotes oral cancer invasion via the E-cadherin/beta-catenin pathway.

Yanamoto S, Kawasaki G, Yamada S, Yoshitomi I, Yoshida H, Mizuno A.

Oral Oncol. 2009 Jun;45(6):521-5. doi: 10.1016/j.oraloncology.2008.07.005. Epub 2008 Sep 18.

PMID:
18804405
18.

Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.

Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR.

Eur Surg Res. 2007;39(4):208-15. Epub 2007 Mar 30.

PMID:
17396032
19.
20.

beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.

Wang XH, Sun X, Meng XW, Lv ZW, Du YJ, Zhu Y, Chen J, Kong DX, Jin SZ.

Oncol Rep. 2010 Oct;24(4):1093-9.

PMID:
20811694

Supplemental Content

Support Center